Calgary, Alberta –TheNewswire -May 14, 2025- Ocumetics Technology Corp (OTCFF). (FRA: 2QBO), a leader in advanced ophthalmic technology, is pleased to announce it has successfullymanufactured its ...

Intraocular lenses (IOLs), implanted in the eye as treatment for cataracts or myopia, are a growing global market in an ageing population, one estimated to be worth more than $4.5 billion by 2022.

Bausch + Lomb, a leading global eye health company, announced a voluntary recall of its Envista Aspire, Envista Envy and certain Envistar intraocular lens injector systems, according to the Food and ...

First Preloaded Toric Available in the United States and Monofocal Option Combine Consistent IOL Delivery with Outstanding Visual Outcomes of enVista® LAVAL, QC, Oct. 27, 2020 /PRNewswire/ -- Bausch + ...

Cataract surgery is a once-in-a-lifetime investment in your eyes that can improve your quality of life for the long term. Advanced lens options can reduce or eliminate the need for glasses after your ...

Bausch + Lomb has recalled lenses used during cataract surgery due to complications when the lenses are used, according to an announcement from the Canada-based eyecare company posted on the U.S. Food ...

BERLIN — Technological advancements and the development of intraocular lenses (IOLs) have significantly improved the care of patients with cataracts, especially for those who would prefer not to wear ...